Link to this page
National Drug File - Reference Terminology
Last uploaded:
July 6, 2018
| Id | http://purl.bioontology.org/ontology/NDFRT/N0000007106
http://purl.bioontology.org/ontology/NDFRT/N0000007106
|
|---|---|
| Preferred Name | Lovastatin [Chemical/Ingredient] |
| Synonyms |
Monacolin K
Lovastatin
6-Methylcompactin
Mevinolin
Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| altLabel | Monacolin K
Lovastatin
6-Methylcompactin
Mevinolin
Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-
|
|---|---|
| prefLabel | Lovastatin [Chemical/Ingredient]
|
| MESH DEFINITION | A fungal metabolite isolated from cultures of Aspergillus terreus. The compound is a potent anticholesteremic agent. It inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It also stimulates the production of low-density lipoprotein receptors in the liver.
|
| MESH DUI | D008148
|
| MESH UI | M0012707
|
| MeSH name | Lovastatin
|
| type | |
| tui |
T109
T121
|
| notation | N0000007106
|
| Semantic type UMLS property | |
| NUI | N0000007106
|
| Ingredient of |
See more
See less
|
| cui | C0024027
|
| NDFRT kind | INGREDIENT_KIND
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |